TARDBP and amyotrophic lateral sclerosis: Although C-terminal TDP-43 fragments are a pathological hallmark of ALS-FTD, overexpression of 35 kDa or 25 kDa fragments does not always cause neurodegeneration in vivo or cell death in vitro [85, 86].